Natco Pharma Ltd.
BSE: 524816 | Sector: Health care |
NSE: NATCOPHARM | ISIN Code: INE987B01026 |
BSE 00:00 | 05 Mar | 832.75 |
-4.05 (-0.48%) |
OPEN
836.80 |
HIGH
852.70 |
LOW
823.95 |
NSE 00:00 | 05 Mar | 833.80 |
-3.85 (-0.46%) |
OPEN
841.05 |
HIGH
853.00 |
LOW
823.10 |
OPEN | 836.80 |
PREVIOUS CLOSE | 836.80 |
VOLUME | 18874 |
52-Week high | 995.05 |
52-Week low | 450.00 |
P/E | 42.97 |
Mkt Cap.(Rs cr) | 15,185 |
Buy Price | 832.75 |
Buy Qty | 300.00 |
Sell Price | 850.00 |
Sell Qty | 128.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Natco Pharma Ltd. (NATCOPHARM) - Half Yearly Result
Particulars (![]() |
Sep '20 | Mar '20 | Sep '19 | Mar '19 | Sep '18 |
Net Sales/Income From Operations | 1011.10 | 867.80 | 922.40 | 948.20 | 1038.10 |
Other Income | 47.10 | 69.50 | 54.30 | 54.40 | 75.40 |
Total Income | 1058.20 | 937.30 | 976.70 | 1002.60 | 1113.50 |
Total Expenditure | 748.10 | 622.50 | 589.70 | 587.60 | 582.20 |
Operating Profit | 310.10 | 314.80 | 387.00 | 415.00 | 531.30 |
Interest | 6.00 | 8.70 | 11.90 | 12.40 | 6.40 |
Gross Profit | 304.10 | 306.10 | 375.10 | 402.60 | 524.90 |
Depreciation | 56.00 | 54.90 | 43.20 | 41.80 | 38.30 |
PBT | 248.10 | 251.20 | 331.90 | 360.80 | 486.60 |
Tax | 62.00 | 56.00 | 73.10 | 66.50 | 119.80 |
Net Profit/(Loss) | 197.60 | 204.60 | 269.90 | 285.40 | 381.70 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 197.60 | 204.60 | 269.90 | 285.40 | 381.70 |
Equity Share Capital | 36.40 | 36.40 | 36.40 | 36.50 | 36.90 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 10.85 | 11.24 | 14.84 | 15.64 | 20.69 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Natco Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices